The role of vimentin as a methylation biomarker for early diagnosis of cervical cancer
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Jung, Samil | - |
dc.contributor.author | Yi, Lisha | - |
dc.contributor.author | Kim, Jinsun | - |
dc.contributor.author | Jeong, Dongjun | - |
dc.contributor.author | Oh, Taejeong | - |
dc.contributor.author | Kim, Chang-Hwan | - |
dc.contributor.author | Kim, Chang-Jin | - |
dc.contributor.author | Shin, Jin | - |
dc.contributor.author | An, Sungwhan | - |
dc.contributor.author | Lee, Myeong-Sok | - |
dc.date.accessioned | 2021-08-12T05:44:35Z | - |
dc.date.available | 2021-08-12T05:44:35Z | - |
dc.date.issued | 2011-05 | - |
dc.identifier.issn | 1016-8478 | - |
dc.identifier.issn | 0219-1032 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/sch/handle/2021.sw.sch/16562 | - |
dc.description.abstract | Multiple cytosine guanine dinucleotides (CpG island) are found in the VIM promoter region. The levels of VIM promoter methylation and VIM gene expression were investigated in 7 cervical cancer cell lines and 50 human tissue samples with a distinctive degree of malignant trans-formation. While multiple CpG sites in the VIM promoter were highly methylated in CIN III and invasive carcinoma cells, they were rarely methylated in normal cells. Our result shows that methylation in the VIM promoter appears to start from CIN I and CIN II, relatively early stages of multistep carcinogenesis. This epigenetic alteration in VIM promoter suggests the availability as a biomarker for the early diagnosis and prevention of cervical cancer. We also show that hypermethylation in the VIM promoter is responsible for transcriptional silencing of the VIM gene in cervical cancer cells. In addition, our result shows that exogenous overexpression of the VIM gene in SiHa cervical cancer cells slightly activated cell proliferation and migration as shown in soft agar colony formation and migration assays. | - |
dc.format.extent | 7 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | 한국분자세포생물학회 | - |
dc.title | The role of vimentin as a methylation biomarker for early diagnosis of cervical cancer | - |
dc.type | Article | - |
dc.publisher.location | 대한민국 | - |
dc.identifier.doi | 10.1007/s10059-011-0229-x | - |
dc.identifier.scopusid | 2-s2.0-79960697150 | - |
dc.identifier.wosid | 000291046100002 | - |
dc.identifier.bibliographicCitation | Molecules and Cells, v.31, no.5, pp 405 - 411 | - |
dc.citation.title | Molecules and Cells | - |
dc.citation.volume | 31 | - |
dc.citation.number | 5 | - |
dc.citation.startPage | 405 | - |
dc.citation.endPage | 411 | - |
dc.type.docType | Article | - |
dc.identifier.kciid | ART001552726 | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | sci | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.relation.journalResearchArea | Biochemistry & Molecular Biology | - |
dc.relation.journalResearchArea | Cell Biology | - |
dc.relation.journalWebOfScienceCategory | Biochemistry & Molecular Biology | - |
dc.relation.journalWebOfScienceCategory | Cell Biology | - |
dc.subject.keywordPlus | HUMAN-PAPILLOMAVIRUS | - |
dc.subject.keywordPlus | DNA | - |
dc.subject.keywordPlus | EXPRESSION | - |
dc.subject.keywordPlus | MIGRATION | - |
dc.subject.keywordPlus | NEOPLASIA | - |
dc.subject.keywordAuthor | cervical cancer | - |
dc.subject.keywordAuthor | epigenetic gene regulation | - |
dc.subject.keywordAuthor | methylation biomarker | - |
dc.subject.keywordAuthor | VIM | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(31538) 22, Soonchunhyang-ro, Asan-si, Chungcheongnam-do, Republic of Korea+82-41-530-1114
COPYRIGHT 2021 by SOONCHUNHYANG UNIVERSITY ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.